Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

GDPR Top 5 Actions You Should Take Now

The EU's General Data Protection Regulation (GDPR) went into effect on May 25th. As most organizations are aware, the GDPR applies not only to EU businesses but also many companies in the U.S. While the deadline is quickly approaching, most organizations are still grappling with the implications of the regulation on their business. Even if your readiness efforts are behind the curve, the GDPR Top 5 Actions You Should Take NOW will help you begin your efforts towards compliance and help mitigate your organization's risk in the short-term.

Click here to download the checklist.

Highly-Acclaimed U.S. Healthcare Fraud and Enforcement Panel

Events

April 23-25, 2018

Bass, Berry & Sims attorney John Kelly will speak at CBI's 15th Annual Pharmaceutical Compliance Congress. John will speak on a point/counterpoint session titled, "Highly-Acclaimed U.S. Healthcare Fraud and Enforcement Panel." It will be held on Tuesday, April 24, 2018 at 11:00 a.m. and feature current and former prosecutors. The session will delve into recent settlements and on-going investigations with the opportunity to hear directly from regulatory leaders across the nation spearheading the charge against healthcare fraud.

Session topics include:

  • A zero-in on the top areas of focus such as PSPs, charitable contributions, off-label, anti-kickback, pricing transparency and the opioid epidemic
  • Gaining insight into emerging enforcement trends and focal points for 2018
  • Collaborating with manufacturers to decrease non-compliance and improve government relations
  • Discussion on how different government agencies communicate and collaborate
  • Discovering how outside counsel responds to the top priorities of the U.S. government
  • Key takeaways from recent high-profile cases to mitigate risk moving forward

The CBI 15th Annual Pharmaceutical Compliance Congress will be held April 23-25, 2018 at the Ritz-Carlton in Washington, D.C. For more information and registration, visit the CBI website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.